Table 6 Summary of Dose Disposition of Complete Study Subjects
From: Effects of paliperidone extended release on the symptoms and functioning of schizophrenia
Complete Study Subjects | Initial Dose | ||||
|---|---|---|---|---|---|
| Â | Â | 3 mg/day | 6 mg/day | 9 mg/day | 12 mg/day |
Dose at the End of Study | 3 mg/day | 40 | 5 | 0 | 0 |
| Â | 6 mg/day | 61 | 122 | 0 | 0 |
| Â | 9 mg/day | 11 | 42 | 11 | 0 |
| Â | 12 mg/day | 15 | 26 | 8 | 9 |